Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 11075 Roselle St
SAN DIEGO CA 92121-1204
Tel: N/A
Website: https://www.tandemdiabetes.com
IR: See website
<
Key People
Kim D. Blickenstaff
Executive Chairman of the Board
John F. Sheridan
President, Chief Executive Officer, Director
Leigh A. Vosseller
Chief Financial Officer, Senior Vice President, Treasurer
Susan M. Morrison
Executive Vice President, Chief Administrative Officer
David B. Berger
Executive Vice President, General Counsel, Secretary
Brian B. Hansen
Chief Commercial Officer, Executive Vice President
Business Overview
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim X2 Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
Financial Overview
For the nine months ended 30 September 2019, Tandem Diabetes Care Inc revenues increased from $107.7M to $253.9M. Net loss decreased 78% to $27.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Change in fair value of stock warrants decrease of 84% to $10.8M (expense), Interest and other expense decrease of 99% to $75K (expense).
Employees: 653 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $3,314M as of Sep 30, 2019
Annual revenue (TTM): $330.11M as of Sep 30, 2019
EBITDA (TTM): -$12.41M as of Sep 30, 2019
Net annual income (TTM): -$23.72M as of Sep 30, 2019
Free cash flow (TTM): $22.92M as of Sep 30, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 59,092,861 as of Oct 30, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization